Mizuho Securities USA’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Mizuho Securities USA’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-75,447	Closed	-$766K	–	241
2023 Q2	$766K	Buy	75,447 +48,576	+181%	+$498K	0.03%	153
2023 Q1	$273K	Buy	+26,871	New	+$273K	0.02%	162

Other funds holding AONC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mizuho Securities USA's AONC Position: Q3 2023 in Review

Mizuho Securities USA sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2023, closing a stake of 75,447 shares — an estimated $766K sold.

Mizuho Securities USA first reported a position in AONC in Q1 2023 and held it in 2 quarters. The position peaked at $766K in Q2 2023. 3 funds tracked by Wall St. Rank hold AONC as of Q3 2023.

Mizuho Securities USA reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Mizuho Securities USA sold 75,447 American Oncology Network, Inc. Class A Common Stock shares in Q3 2023, an estimated $766K.
Mizuho Securities USA first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
Mizuho Securities USA's American Oncology Network, Inc. Class A Common Stock position peaked at $766K in Q2 2023.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2023.

Based on Mizuho Securities USA's 13F filing for Q3 2023, filed 9 Nov 2023.